One of the problems we talked about in my office is the problem of shell corporations. They are used for tax avoidance and evasion.
And should it continue to do so?
Should it be something the IRS looks into if there appears to be inconsistent reporting to determine whether the reporti...
There is a collections gap between what taxpayers owe and what the IRS collects. It is estimated to be about $400 billio...
We witnessed the administration leaning on both independent regulators and on agencies of government like DOJ that are s...
The IRS has a history from bygone days of having been used as a political weapon.
The concern that I have is that we are not seemingly addressing that problem.
My concern is that you get these companies that come in that buy up a drug manufacturer, add no value, invest in no rese...
This is important to us.
I think in the area of de facto monopoly, it would be hard to identify an agency of government that actually has respons...
I think one can generally divide the pharmaceutical market into three categories.